J Fidlerová

Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy

Zdeněk Kleibl, J Fidlerová, Petra Kleiblová et al. · Neoplasma · 2009 · 67 citations

Oncology, Fluoropyrimidine-based Chemotherapy, Oncogenic Agent +15

Caspase-2 is involved in cell death induction by taxanes in breast cancer cells

Michael Jelínek, Kamila Balušíková, Dana Kopperová et al. · Cancer Cell International · 2013 · 32 citations · Full text

Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients

J Fidlerová, Petra Kleiblová, Matej Bilek et al. · Cancer Chemotherapy and Pharmacology · 2009 · 28 citations

Serious Toxicity, Fluoropyrimidine-treated Cancer Patients, Dihydropyrimidinase Gene Alterations +8

Contribution of the β-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity

J Fidlerová, Petra Kleiblová, Stanislav Kormunda et al. · Pharmacological Reports · 2012 · 17 citations

Biochemistry, Gene Alterations, Medicine +9

Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity

Ivana Tichá, Petra Kleiblová, J Fidlerová et al. · Cancer Chemotherapy and Pharmacology · 2009 · 13 citations

Large Intragenic Rearrangements, Biochemistry, Medicine +7